Log in to save to my catalogue

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance i...

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance i...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899616

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer

About this item

Full title

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer

Publisher

England: John Wiley & Sons, Inc

Journal title

Cancer science, 2023-02, Vol.114 (2), p.463-476

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Although histone H3K4 methyltransferase SETD1A is overexpressed in various cancer types, the molecular mechanism underlying its overexpression and its target genes in pancreatic ductal adenocarcinoma (PDAC) remain unclarified. We conducted immunohistochemical staining for SETD1A in 105 human PDAC specimens to assess the relationship between SETD1A...

Alternative Titles

Full title

Identification of a novel target of SETD1A histone methyltransferase and the clinical significance in pancreatic cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899616

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9899616

Other Identifiers

ISSN

1347-9032

E-ISSN

1349-7006

DOI

10.1111/cas.15615

How to access this item